SCHEMBL1076597

SCHEMBL1076597

COc1cc(F)c(-c2c(C)nc(Cl)n2-c2ccc(C)cc2)c(F)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.36
RAB9A P51151 2/20 0.36
NPSR1 Q6W5P4 2/20 0.36
GRM8 O00222 1/20 0.36
CYP1A2 P05177 1/20 0.36
GRM7 Q14831 1/20 0.36
HPGD P15428 2/20 0.35
HTT P42858 2/20 0.35
CUL4A Q13619 1/20 0.35
SMN1; SMN2 Q16637 3/20 0.34
LMNA P02545 2/20 0.34
NPC1 O15118 1/20 0.34
HSP90AA1 P07900 1/20 0.34
MAPT P10636 1/20 0.34
XBP1 P17861 1/20 0.34
MAPK1 P28482 1/20 0.34
TLR9 Q9NR96 1/20 0.34
TP53 P04637 2/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1075011 0.92 GLA (0.40) NPSR1GRM8CYP1A2GRM7HPGD
SCHEMBL1074420 0.91 CYP1A2 (0.38) GRM8CYP1A2GRM7PTGS1PTGS2
SCHEMBL1076149 0.89 CYP1A2 (0.36) ALDH1A1NPSR1GRM8CYP1A2GRM7
SCHEMBL1074585 0.88 PDE4B (0.37) GRM8CYP1A2GRM7EGFR
SCHEMBL1902748 0.87 FPR2 (0.43) HTTSMN1; SMN2LMNAMAPT
SCHEMBL1073034 0.86 CYP1A2 (0.34) ALDH1A1GRM8CYP1A2GRM7PTGS1
SCHEMBL1071794 0.85 GRM8 (0.34) RAB9AGRM8CYP1A2GRM7SMN1; SMN2
SCHEMBL1075676 0.85 CYP11B1 (0.40) GRM8CYP1A2GRM7PTGS2
SCHEMBL1073182 0.84 OXTR (0.41) MEN1KMT2A
SCHEMBL1074801 0.84 CYP1A2 (0.40) ALDH1A1CYP1A2HPGDHTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110045101-A1 FUNGICIDAL SUBSTITUTED AZOLES E.I. DU PONT DE NEMOURS AND COMPANY (US) 2011-02-24 US claimed
EP-2274284-A2 FUNGICIDAL SUBSTITUTED AZOLES E. I. Du Pont de Nemours and Company (US) 2011-01-19 EP claimed
WO-2009137651-A2 FUNGICIDAL SUBSTITUTED AZOLES E. I. DU PONT DE NEMOURS AND COMPANY (US) 2009-11-12 WO claimed
US-20110045101-A1 FUNGICIDAL SUBSTITUTED AZOLES E.I. DU PONT DE NEMOURS AND COMPANY (US) 2011-02-24 US disclosed
EP-2274284-A2 FUNGICIDAL SUBSTITUTED AZOLES E. I. Du Pont de Nemours and Company (US) 2011-01-19 EP disclosed
WO-2009137651-A2 FUNGICIDAL SUBSTITUTED AZOLES E. I. DU PONT DE NEMOURS AND COMPANY (US) 2009-11-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110045101-A1 FUNGICIDAL SUBSTITUTED AZOLES CBR3, NOX3, CBR1 ALDH1A1 2522/4885RAB9A 1245/4885NPSR1 2059/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.